Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to
|
|
- Diana Berry
- 6 years ago
- Views:
Transcription
1 The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for the regulation of natural health products sold in Canada. The communiqué is released to the Canadian public the first week of each month via the NHPD s electronic bulletin. Subscription to this e-bulletin is available at Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to NHPD_DPSN@hc-sc.gc.ca. TABLE OF CONTENT: ******************************************************************** Each NHPD Monthly Communiqué is separated into five sections for ease of reference. These are: Product Licensing Information, Site Licensing Information, Compliance Corner, Clinical Trial Information and Other Information. PRODUCT LICENSING INFORMATION Final Classification of Medicinal Ingredients listed in the Category IV Monographs/TPD Labelling Standards P. 2 Determining Proper and Common Names for Homeopathic Medicines P. 2 Classification and Regulation of Gotukola P. 4 Correction to the Response time for PDNs and IRNs P. 4 Rationale for Combination Products P. 5 Clarification Regarding Vitamin A and Vitamin E Conversion Factors P. 5 o Vitamin A Conversion Table P. 5 o Examples Using Vitamin A Conversion Factors P. 6 o Vitamin E Conversion Tables P. 7 o Examples Using Vitamin E Conversion Factors P. 8 Common Errors and Deficiencies P. 8 SITE LICENSING INFORMATION P. 9 COMPLIANCE CORNER Site Licensing and Health Canada's compliance approach for natural health P. 9 products POST January 1, CLINICAL TRIAL INFORMATION P. 10 OTHER INFORMATION P. 10 Page 1 of 10
2 PRODUCT LICENSING INFORMATION: Final Classification of Medicinal Ingredients listed in the Category IV Monographs/TPD Labelling Standards For over a year, members of the Natural Health Products Directorate and Therapeutic Products Directorate have been working diligently on the classification of roughly 425 medicinal ingredients found in the Category IV Monographs/TPD Labelling Standards. We are pleased to announce that this exercise is now complete and all medicinal ingredients found in these monographs and labelling standards have been officially classified. The list of ingredients, which is available on-line at is organized by the name of the monograph or labelling standard and includes the ingredient name and its classification (i.e. as a natural health product or drug) In addition, we would also like to announce that the conversion of several Category IV Monographs/TPD Labelling Standards into official natural health product monographs is progressing well. Several new monographs have been drafted and are currently in the peer-review stage. It is anticipated that the complete conversion will be done by Spring 2006, at which time applicants citing these new monographs will see their applications processed within a 60-day timeframe. Determining Proper and Common Names for Homeopathic Medicines Part 4 of the Product Licence Application (PLA) Form asks that applicants provide the proper and common names for each medicinal ingredient found in their natural health product. The following guidelines apply specifically to applications for homeopathic medicines and are developed to assist applicants in differentiating between the proper name and common name for medicinal ingredients in homeopathic medicines. Please refer to this information when filling out the proper and common name fields on the Product Licence Application form. **Please note that the proper name is not necessarily the name listed at the top of the homeopathic monograph in a homeopathic pharmacopoeia. Proper Names 1. When the starting material for the medicinal ingredient is a plant or a plant material, an alga, a fungus, a bacterium, a nonhuman animal material or a probiotic, the proper name will be the current Latin name of its genus and, if any, its specific epithet. Example: Allium cepa. 2. When the ingredient is a mineral or chemical, the proper name will be any unambiguous name. Example: ferrous iodide. 3. When the ingredient is a vitamin, the proper name will be a name set out for that vitamin in Item 3 of Schedule 1 of the Natural Health Products Regulations. These are: biotin, folate, niacin, pantothenic acid, vitamin A, thiamine, riboflavin, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E and vitamins K1 and K2. 4. When the ingredient is a nosode, the proper name is the current scientific Latin binomial of the diseasecausing agent. Example: Bordetella pertussis. Page 2 of 10
3 5. When the ingredient is a sarcode, the proper name is the name of the tissue used. Example: Thyroid The following Internet links may be useful in identifying the proper name of a given medicinal ingredient for your homeopathic medicines: For plants and plant materials: For animals and animal materials: For chemicals: Common Names For homeopathic medicines, the common name of a medicinal ingredient is any name by which it is commonly known, provided it is a name listed in one of the accepted homeopathic pharmacopoeias. The following table provides a few examples: Proper Name Allium cepa Ferrous iodide Bordetella pertussis Thyroid Sodium chloride Acceptable Common Names onion, oignon ferrum iodatum, iodure de fer pertussinum, pertussin, coqueluchin thyroidinum, thyroid gland, thyroïde natrum muriaticum, salt, table salt, sea salt, sel marin, chlorure de sodium marin The NHPD recognizes that there may be cases where the proper name and common name will be identical. For example, the proper name for basil is Ocimum basilicum and the common name may be Ocimum basilicum or basil. If Ocimum basilicum is chosen as the common name, it is only necessary to list the name once (in the proper name field of the PLA form). In this case, the common name field may be left blank because the common name chosen is identical to the proper name. However, if basil is chosen as the common name it must be listed on the PLA form because it is different from the proper name (which, as indicated, is Ocimum basilicum). Page 3 of 10
4 Classification and regulation of gotukola Products containing gotukola crude herb or part(s) of the herb are now classified and regulated as natural health products. Individuals and businesses seeking authorization to market these products in Canada are first required to obtain the necessary product and site licenses. Products containing gotukola extract or active principles thereof will continue to be classified and regulated as prescription drugs. The Natural Health Products Regulations prohibit natural health products from containing a substance or a combination of substances currently listed on Schedule F of the Food and Drugs Regulations. Schedule F is a listing of substances which require a prescription in Canada. Since the coming into force of the Regulations in 2004, there have been ongoing discussions regarding the current inclusion of substances or combinations of substances on Schedule F of the Food and Drug Regulations which may otherwise be considered natural health products. Among these substances is Centella asiatica, commonly known as gotukola. In December 2005, following extensive discussions between departmental representatives and industry stakeholders, a decision was reached regarding the classification and regulation of this particular substance. The present listing of gotukola on Schedule F is set out as "Centella asiatica extract and active principles thereof." While from a scientific perspective, a product containing gotukola crude herb or part(s) of the herb consists of "Centella asiatica extract and active principles thereof", it was agreed that the Schedule F listing was intended to include extract products specifically, and not products which contain the crude herb or part(s) thereof. The decision was thus made that the current Schedule F listing applies to extracts and active principles only and does not apply to products consisting of the crude herb or parts thereof. Correction to the Response Time for PDNs and IRNs In the December 2005 issue of the Monthly Communiqué, we had indicated in our article entitled Intent to Withdraw Notice will no longer be sent after January 1, 2006 that applicants are required to respond to a Processing Deficiency Notice (PDN) or Information Request Notice (IRN) within 30 business days. However, we wish to inform you that this should have said 30 calendar days. We apologize for this oversight on our part. As of January 1st, 2006, applicants who do not respond within the time frame indicated in the PDN or IRN (30 calendar days) will receive a Notice of Withdrawal and their applications will be immediately removed from our review queue. Page 4 of 10
5 Rationale for Combination Products The NHPD allows for any combination of medicinal substances listed in Schedule 1 of the Natural Health Products Regulations provided that this combination contributes to the recommended use/purpose of the product and does not present any safety concerns. However, for combination products that contain medicinal ingredients that do not contribute directly or obviously to the recommended use/purpose indicated, an explanation, or rationale, for the addition of these medicinal ingredients to the product is required. Applicants who cannot provide a strong rationale supporting the inclusion of a medicinal ingredient in their combination will be asked to remove that ingredient from the formulation. Clarification Regarding Vitamin A and Vitamin E Conversion Factors Over the past months, we have received a number of questions regarding the vitamin A and vitamin E conversion factors that were published in the October and November 2005 issues of the NHPD Monthly Communiqué. As such, it is the intent herein to provide clarification and examples on how to use the conversion factors for each of these substances. VITAMIN A The following is an elaborated version of the table published in the October issue of the Monthly Communiqué and presents vitamin A conversion factors. Quantity of Source Material 1 µg all-trans-retinol (1 µg RAE) (synonym: vitamin A) 1 µg of all-trans-retinyl acetate (synonym: vitamin A acetate) 1 µg all-trans-retinyl palmitate (synonym: vitamin A palmitate) 1 µg supplemental all-trans-beta-carotene (synonym: beta-carotene) i.e. as an isolate 1 µg dietary all-trans-beta-carotene (synonym: beta-carotene) i.e. in plant (e.g. carrot powder), algal, or bacterial matrices 1 µg supplemental all-trans-alpha-carotene or all-trans-betacryptaxanthin (synonyms: alpha-carotene and beta-cryptaxanthin) i.e. as isolates 1 µg dietary all-trans-alpha-carotene or all-trans-beta-cryptaxanthin (synonyms: alpha-carotene and beta-cryptaxanthin) (e.g. in citrus fruit powder) Vitamin A Activity (in International Units) 3.33 IU 2.91 IU 1.82 IU 1.67 IU 0.28 IU 0.83 IU 0.14 IU 1 Retinol Activity Equivalent (1 µg RAE): = 1 µg all-trans-retinol = 2 µg supplemental all-trans-beta-carotene = 12 µg dietary all-trans-beta-carotene = 24 µg dietary all-trans-alpha-carotene or all-trans-beta-cryptaxanthin Page 5 of 10
6 Points of Clarification: In the PLA form, the quantity of vitamin A must always be provided in terms of retinol activity equivalents (RAE) (i.e. in µg of all-trans-retinol), irrespective of the source material used. International Units (IU) may be provided as optional additional information on the PLA form in the potency field and on product labels. The only acceptable claim for beta-carotene (for compendial applications) is as a source of vitamin A (e.g. beta-carotene as provitamin A ). In the PLA form vitamin A should be identified as the proper name, and vitamin A, retinol or betacarotene as provitamin A should be identified as the common name. 1 IU of vitamin A activity = 1 IU of beta-carotene activity because beta-carotene is acting as a source of vitamin A. Examples using the Vitamin A Conversion Factors: a) Converting IU of vitamin A activity into RAE Convert 500 IU of vitamin A activity from all-trans-retinol into RAE: (500 IU vitamin A) x (1 µg RAE) = 150 µg RAE 3.33 IU vitamin A b) Converting weight of vitamin A source material into RAE Convert 2000 µg of supplemental all-trans β-carotene (i.e. β-carotene dissolved in vegetable oil) into RAE. Step 1: Convert the source material into IU activity using the conversion table. NOTE - According to the conversion table, 1 µg of supplemental β-carotene is equal to 1.67 IU of vitamin A: (2000 µg of supplemental β-carotene) x (1.67 IU vitamin A) = 3340 IU vitamin A 1 µg supplemental β-carotene Step 2: convert IU activity into RAE: (3340 IU vitamin A) x (1 µg RAE) = 1000 µg RAE 3.33 IU vitamin A ANSWER: 2000 µg of supplemental all-trans β-carotene = 1000 µg RAE Convert 2000 µg of dietary all-trans β-carotene (i.e. in carrot powder) into RAE. Step 1: Convert the source material into IU activity using the conversion table. NOTE - According to the conversion table, 1 µg of dietary β-carotene is equal to 0.28 IU of vitamin A: (2000 µg of dietary β-carotene) x (0.28 IU vitamin A) = 560 IU Vitamin A 1 µg supplemental β-carotene Page 6 of 10
7 Step 2: Convert IU activity into RAE: (560 IU vitamin A) x (1 µg RAE) = 168 µg RAE 3.33 IU vitamin A ANSWER: 2000 µg of dietary all-trans β-carotene = 168 µg RAE In order to facilitate the application process and reduce the number of Information Request Notices (IRNs) sent out, the NHPD kindly asks that applicants provide their vitamin A calculations with their product licence submissions. VITAMIN E The following two tables present vitamin E conversion factors in a more simplistic format compared to the table published in the November issue of the Monthly Communiqué. The first table shows how to convert the weight of vitamin E source material into the quantity of vitamin E as alpha-(α)-tocopherol equivalents (ATE) (i.e. in mg of RRR-α-tocopherol) and the second table shows the factors for converting International Units (IU) of vitamin E into the quantity of vitamin E as ATE. Source Material Quantity of Vitamin E (ATE) International Units (IU) 1 mg RRR-α-tocopherol 1.00 mg mg RRR-α-tocopheryl acetate mg mg RRR-α-tocopheryl succinate mg mg all racemic(rac)-α-tocopherol mg mg all rac-α-tocopheryl acetate mg mg all rac-α-tocopheryl succinate mg Source Material Quantity of Vitamin E (ATE) 1 IU RRR-α-tocopherol 0.67 mg 1 IU RRR-α-tocopheryl acetate 0.67 mg 1 IU RRR-α-tocopheryl succinate 0.67 mg 1 IU all rac-α-tocopherol 0.45 mg 1 IU all rac-α-tocopheryl acetate 0.45 mg 1 IU all rac-α-tocopheryl succinate 0.45 mg Points of Clarification: In the PLA form, the quantity of vitamin E must always be provided in terms of ATE, irrespective of the source material used. IU may be provided as optional additional information in the PLA form in the potency field and on product labels. RRR-α-tocopherol is the only natural source of vitamin E. The other five forms are considered synthetic. RRR and all rac-α-tocopherol are more specific names for what were previously known as d and dl-αtocopherol, respectively. Page 7 of 10
8 Example using the Vitamin E Conversion Factors: a) Converting weight of vitamin E source material into ATE. Convert 200 mg of RRR-α-tocopheryl succinate into ATE: (200 mg RRR-α-tocopheryl succinate) x (0.807 mg ATE) = mg ATE 1 mg RRR-α-tocopheryl succinate Convert 200 mg all rac-α-tocopheryl acetate into ATE: (200 mg all rac-α-tocopheryl acetate) x (0.456 mg ATE) = 91.2 mg ATE 1 mg all rac-α-tocopheryl acetate b) Converting vitamin E activity in terms of IU into ATE. Convert 400 IU RRR-α-tocopheryl succinate into ATE: (400 IU RRR-α-tocopheryl succinate) x (0.67 mg ATE) = 268 mg ATE 1 IU RRR-α-tocopheryl succinate Convert 400 IU all rac-α-tocopherol into ATE: (400 IU all rac-α-tocopherol) x (0.45 mg ATE) = 180 mg ATE 1 IU all rac-α-tocopherol In order to facilitate the application process and reduce the number of Information Request Notices (IRNs) sent out, the NHPD asks that applicants provide their vitamin E calculations with their product licence submissions. Common Errors and Deficiencies The following is a list of common errors and deficiencies found in product licence applications sent to the NHPD. These errors, though they may seem minor in some cases, can lead to major time delays and can be easily avoided if applicants take the time to properly prepare and review their applications before submitting them to the NHPD. 1. Duration of Use information: Duration of use information should only appear in the Duration of Use field found in Part 4, Section 3 of the PLA form. It has been noted that duration of use information has erroneously appeared in the risk information fields (Cautions and Warnings, Contra-indications, Known Adverse Reactions) also found in Part 4, Section 3 of the PLA form. This error leads to unnecessary questions, additional clarifications and review delays. If the duration of use information is too long for the Duration of Use field, the applicant can put a star annotation in the field (*) and include the annotated duration of use text somewhere else on the same page of the PLA form, cross referencing it with the same symbol (e.g. *). ******************************************************************** Page 8 of 10
9 SITE LICENSING INFORMATION: This month s focus was to have been on storage and maintenance of facilities. However, with the site licensing provisions of the Regulations coming into force on January 1, 2006, all of our site licensing resources have been focussed wholly on processing site licence submissions. Next month will see the resumption of our educational theme-based series on site licensing, with part four focussing on storage and maintenance of facilities. COMPLIANCE CORNER: ******************************************************************** In addition to authorizing the sale of natural health products, the NHPD is also responsible for coordinating compliance efforts targeted at natural health products that are not in compliance with the Natural Health Product Regulations and related policies and/or that pose an unacceptable risk to the health and safety of Canadians. Site Licensing and Health Canada's compliance approach for natural health products POST January 1, In order to market natural health products in Canada, the Natural Health Products Regulations first require individuals and businesses to obtain the necessary product and site licences. Prior to January 1, 2006, Health Canada s compliance efforts had focussed on products, targeting those that A) present a significant risk to the health of the population or B) have not been issued a submission number prior to their product category priority date. However, on January 1, 2006, the site licensing provisions of the Regulations came into effect and compliance actions are now focussing on both products and sites. Individuals and businesses without a valid site licence will be subject to compliance action by the Health Products and Food Branch Inspectorate. For example, products for which a site license has not been obtained by the necessary individuals or businesses and that are referred to the Inspectorate by the Canadian Border Services Agency, will be recommended for refusal of entry into Canada. When products are encountered in Canada, for which a site license has not been obtained by the necessary individuals or businesses, the Inspectorate will take compliance and enforcement action in accordance with POL Having a valid product licence or submission number without a site license does not constitute authorization to sell nor does it exempt an individual or business from compliance action. The same applies to natural health products whose priority categorization has not yet passed (i.e. products found in priorities 4, 5, and 6). Priority 4, 5 and 6 products without a valid site licence will be subject to compliance action. Industry stakeholders that have not yet applied for either licence are encouraged to do so immediately. ******************************************************************** Page 9 of 10
10 CLINICAL TRIAL INFORMATION: No new information to report this month. However, keep an eye out for the second issue of the NHPD Quarterly Report (scheduled for release in late February 2006), which will include a progress report from the NHPD s Clinical Trials Unit describing some of its recent accomplishments, which include the elimination of the clinical trial application backlog. The NHPD Quarterly Report is available on-line at OTHER INORMATION: No new information to report this month. ******************************************************************** Page 10 of 10
Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to
The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for the regulation of natural health products sold in Canada.
More informationNHPD Monthly Communiqué
NHPD Monthly Communiqué Vol. 3, Issue 5 February 2008 The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for
More informationCOMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE
COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE June 13 2013 Version 3.0 i FOREWORD Guidance documents are meant to provide assistance to industry and health care practitioners on how to comply
More informationM I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents
M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents Communiqué for Health Industry Clients on the Legal Retainer Program Canada s New Natural Health Products Regulations On
More informationFood and Drug Regulations - Project Number Schedule F
Graham Spry Building 250 Lanark Avenue Address Locator: 2005D Ottawa, Ontario K1A 0K9 09-128254-482 Provincial and Territorial Deputy Ministers of Health Provincial and Territorial Drug Program Managers
More informationBotanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges.
Botanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges.part III- Marketing botanical food supplements in Italy Vittorio Silano
More informationClassification of Products at the Food Natural Health Product Interface: Products in Food Formats
Classification of Products at the Food Natural Health Product Interface: Products in Food Formats Natural Health Products Directorate Food Directorate June 2010 Version 2.0 Health Canada is the Federal
More information***II POSITION OF THE EUROPEAN PARLIAMENT
EUROPEAN PARLIAMENT 1999 2004 Consolidated legislative document 13 March 2002 2000/0080(COD) PE2 ***II POSITION OF THE EUROPEAN PARLIAMENT adopted at second reading on 13 March 2002 with a view to the
More informationREGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.
REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. CHAPTER I Scope and definitions. Article 1 Scope.
More informationSeven Easy Steps To Assess Non-Compliance Of A Food Supplement
Seven Easy Steps To Assess Non-Compliance Of A Food Supplement Three easy immediate checks of the label 1. If a product is labelled as Dietary Supplement, it is non-compliant. All food supplements must
More informationOfficial Journal of the European Union REGULATIONS
L 259/2 REGULATIONS COMMISSION DELEGATED REGULATION (EU) 2017/1798 of 2 June 2017 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional
More informationGuidance Document The Use of Probiotic Microorganisms in Food
Guidance Document The Use of Probiotic Microorganisms in Food Food Directorate Health Products and Food Branch Health Canada April 2009 Page 1 of 8 I. Introduction Purpose 1. The purpose of this Guidance
More informationInterim Policy on the Use of Expired Interim Marketing Authorizations Related to Food Fortification
Interim Policy on the Use of Expired Interim Marketing Authorizations Related to Food Fortification March 2017 Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch 1 Table
More informationCUTTING THROUGH LABELING CONFUSION
esha presents CUTTING THROUGH LABELING CONFUSION A GUIDE FOR UNDERSTANDING THE FDA'S CHANGES TO NUTRIENTS, DAILY VALUES, AND FORMATTING OF NUTRITION FACTS LABELS An ebook from esha RESEARCH CONTENTS What
More informationGUIDELINES ON NUTRITION LABELLING CAC/GL
GUIDELINES ON NUTRITION LABELLING CAC/GL 2-1985 Adopted in 1985. Revised in 1993 and 2011. Amended in 2003, 2006, 2009, 2010, 2012, 2013, 2015, 2016 and 2017. ANNEX adopted in 2011. Revised in 2013, 2015,
More informationFM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition
ก 2553 ก ก ก (DIRECTIVE 2002/46/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCILof 10 June 2002 on the approximation of the laws of the Member States relating to food supplements) : ก ก ก ก : ก ก : 10
More informationBill C-51 and Natural Health Products - The Facts
Bill C-51 and Natural Health Products - The Facts 1. How will Bill C-51 change the way natural health products are regulated? Bill C-51 will not affect the way that natural health products are regulated
More informationG O L D E N S E A L R O O T P O W D E R
T H E A M E R I C A N H E R B A L P R O D U C T S A S S O C I A T I O N S GUIDANCE CA PROPOSITION 65: G O L D E N S E A L R O O T P O W D E R AUGUST 2016 This document is the property of the American Herbal
More informationOfficial Journal of the European Communities
L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION
More informationProduct Information:
Product Information: Pro-Phree 1 of 5 Nutrition support of infants and toddlers who require extra calories, minerals, and vitamins and/or protein restriction. Use under medical supervision. Protein-free
More informationMultigenics Chewable
8. Children's Health and Development Multigenics Chewable Multigenics Chewable is a high quality multiple vitamin and mineral supplement with excellent nutrient bioavailability designed especially for
More informationPharmacopeial Perspectives on Vitamin Analysis
International Vitamin Conference May 15, 2014- Washington DC Pharmacopeial Perspectives on Vitamin Analysis Gabriel I. Giancaspro, Ph.D. Vice President, Foods, Dietary Supplements and Herbal Medicines
More informationPaper No.: 01. Paper Title: FOOD CHEMISTRY. Module 25: Fat soluble vitamins: Properties, stability and. modes of degradation
Paper No.: 01 Paper Title: FOOD CHEMISTRY Module 25: Fat soluble vitamins: Properties, stability and modes of degradation CHAPTER 25 FAT SOLUBLE VITAMINS Properties, Stability & Modes of degradation Vitamins,
More information2003 No. 273 FOOD. Food Supplements Regulations (Northern Ireland) 2003 STATUTORY RULES OF NORTHERN IRELAND
STATUTORY RULES OF NORTHERN IRELAND 2003 No. 273 FOOD Food Supplements Regulations (Northern Ireland) 2003 Made - - - - - 20th May 2003 Coming into operation 1st August 2005 The Department of Health, Social
More informationINTERIM NOTIFICATION PROGRAM LOW RISK VETERINARY HEALTH PRODUCTS OVERVIEW
INTERIM NOTIFICATION PROGRAM LOW RISK VETERINARY HEALTH PRODUCTS OVERVIEW Table of Contents 1.0 Purpose 2.0 Background 3.0 Scope 4.0 Definitions 5.0 Identification of a Notified Product 6.0 Requirements
More informationA GUIDE TO NUTRITION LABELING
A GUIDE TO NUTRITION LABELING AN INTRODUCTION Every day, Eurofins experts around the globe field questions from clients about nutrition labeling, allergen claims, and the Nutrition Labeling and Education
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February
More informationWorking Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT
COMMISSION STAFF WORKING DOCUMENT on certain requirements for FSMPs [Supporting Document for the Expert Group meeting of 7 February 2014] Introduction Following the discussions in the Expert Group meeting
More informationFortisip Powder A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration
A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration Features Flexibility to prepare to various energy concentrations: 1kcal/ml, 1.5kcal/ml
More informationEUROPEAN PARLIAMENT C5-0640/2001. Common position. Session document 2000/0080(COD) 10/12/2001
EUROPEAN PARLIAMENT 1999 Session document 2004 C5-0640/2001 2000/0080(COD) EN 10/12/2001 Common position adopted by the Council on 3 December 2001 with a view to the adoption of a Directive of the European
More informationCANADA S NEW FOOD LABELLING REGULATIONS
CANADA S NEW FOOD LABELLING REGULATIONS an ebook from ESHA Research 2 TABLE OF CONTENTS Introduction... 3 The Nutrition Facts Overview... 4 Changes in Daily Value... 4 Formatting... 5 Nutrient Changes...
More informationNatural Health Product Raw Material Policy
Natural Health Product Raw Material Policy Natural Health Products Directorate Health Products and Food Branch October 2006 Health Canada is the Federal department responsible for helping Canadians maintain
More informationcodex alimentarius commission
codex alimentarius commission FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS WORLD HEALTH ORGANIZATION JOINT OFFICE: Viale delle Terme di Caracalla 00100 ROME Tel.: 39.06.57051 Telex: 625825-625853
More informationCommunity provisions, relevant national rules may apply without prejudice to the provisions of the Treaty.
L 404/26 REGULATION (EC) No 1925/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods THE EUROPEAN PARLIAMT
More informationهيئة التقييس لدول مجلس التعاون لدول الخليج العربية
هيئة التقييس لدول مجلس التعاون لدول الخليج العربية GCC STANDARDIZATION ORGANIZATION (GSO) Final Draft GSO 05 FDS 1366 / 2016 اشت ارطات عامة لتداول األغذية المستعملة ألغ ارض طبية خاصة General Requirements
More informationDIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004
30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,
More informationCommodity Provision Method Principle Type Infant Formula. Turbidimetric Formula. Total B12 as cyanocobalamin
Agenda Item 3 JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON METHODS OF ANALYSIS SAMPLING Thirty-seventh th Session Budapest, Hungary, 22 26 February 2016 (information prepared by vice-chair
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 08.05.2000 COM(2000) 222 final 2000/0080 (COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the approximation of the laws of
More informationRegulatory framework
Regulatory framework Status and future changes for sports nutrition Nick Morgan, Performance Director, Glanbia Performance NutritionMember of ESSNA Food Matters Live 2014 19 th November - ExCeL, London
More informationThe Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years
The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years Gary L. Yingling Food Policy Impact December 2011 Copyright 2011 by K&L Gates LLP. All rights reserved. Brief Historical
More informationProposed Amendments to the Cannabis Regulations: Edible Cannabis, Cannabis Extracts and Cannabis Topicals
Proposed Amendments to the Cannabis Regulations: Edible Cannabis, Cannabis Extracts and Cannabis Topicals Health Canada s 2019 Regulatory Consultation 1 Purpose The purpose of this presentation is to provide
More informationOfficial Journal of the European Union
L 230/8 EN 25.8.2016 COMMISSION REGULATION (EU) 2016/1413 of 24 August 2016 amending Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods other than those referring
More informationUpdate FDA/Center for Food Safety and Applied Nutrition
Update FDA/Center for Food Safety and Applied Nutrition Comments by Susan Mayne, Ph.D. Director Center for Food Safety and Applied Nutrition FDLI Annual Conference May 3, 2018 Food Safety, Nutrition and
More informationMulti-Vitamin PART OF YOUR ESSENTIALS PACK
Supplement Details Multi-Vitamin PART OF YOUR ESSENTIALS PACK A perfectly balanced all rounder. Our high quality multivitamin gives you a well balanced daily dose of a plethora of essential vitamins and
More informationProduct Information: Ketonex -1
Product Information: 1 of 5 Nutrition support of infants and toddlers with maple syrup urine disease (MSUD). Isoleucine-, leucine- and valine-free. Use under medical supervision. Branched-chain amino acid-free
More informationFood Directorate Update: Supplemented Foods and Nutrition Labelling
Food Directorate Update: Supplemented Foods and Nutrition Labelling Dr. William Yan Bureau of Nutritional Sciences, Food Directorate, Health Canada Canadian Health Food Association Expo West Regulatory
More informationProduct Information: PediaSure Grow & Gain
Product Information: PediaSure Grow & Gain 1 of 5 PediaSure Grow & Gain is clinically proven * nutrition to help kids grow, and is a nutritious supplement for kids falling behind on growth. 1,2,3,4,5 May
More informationRE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements
Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov
More informationHow to Read Labels Dr. Dan Fouts
How to Read Labels Dr. Dan Fouts Federal Trade Commission (FTC) Enforces laws outlawing "unfair or deceptive acts or practices Role - to ensure that consumers get accurate information about dietary supplements
More informationSTANDARD FOR FOLLOW-UP FORMULA CODEX STAN Adopted in Amended in 1989, 2011, 2017.
STANDARD FOR FOLLOW-UP FORMULA CODEX STAN 156-1987 Adopted in 1987. Amended in 1989, 2011, 2017. CODEX STAN 156-1987 2 1. SCOPE This standard applies to the composition and labelling of follow-up formula.
More informationRaritan Pharmaceuticals, Inc. 6/20/17
Raritan Pharmaceuticals, Inc. 6/20/17 U.S. Food & Drug Administration Division of Pharmaceutical Quality Operations I New Jersey District 10 Waterview Boulevard, 3rd Floor Parsippany, NJ 07054 June 20,
More informationConverting Nutrient Units for the New 2016 Nutrition Facts Label ESHA Research
Converting Nutrient Units for the New 2016 Nutrition Facts Label ESHA Research January 31, 2017 Genesis R&D Training Advanced Genesis Workshop February 7-8, 2017 Lombard, IL This workshop session will
More informationProduct Information: Tyrex -1
Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free
More informationRe: Important changes to Fortisip Powder
18 June 2014 Dear valued customer Nutricia Ltd 37 Banks Road, Mount Wellington Auckland, New Zealand PO Box 62 523 Greenlane, Auckland 1546 Tel: 0800 688 747 Re: Important changes to Fortisip Powder Nutricia
More informationB.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations
B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British
More informationINTERIM NOTIFICATION PROGRAM LOW RISK VETERINARY HEALTH PRODUCTS NOTIFICATION APPLICATION FORM GUIDANCE
INTERIM NOTIFICATION PROGRAM LOW RISK VETERINARY HEALTH PRODUCTS NOTIFICATION APPLICATION FORM GUIDANCE Section # GUIDANCE 1-2 BRAND NAME The brand name refers to the proprietary or product name and should
More informationInternational Food Systems QUALITY SERVICE INNOVATION IN FOOD INGREDIENTS
Product Specification Sheet Organic Sprouted Purple Corn Blend W/ Sprouted Grains Product No: QH 24-3 Description: Organic Sprouted Purple Corn Blend QH 24-3 is a dark colored grain blend intended for
More informationProduct Information: PediaSure Grow & Gain Therapeutic Nutrition
Product Information: PediaSure Grow & Gain Therapeutic Nutrition Shake 1 of 5 PEDIASURE GROW & GAIN is clinically proven * nutrition to help kids grow and is a nutritious supplement for kids falling behind
More informationProduct Information: Propimex -1
Product Information: Propimex -1 1 of 5 Nutrition support of infants and toddlers with propionic or methylmalonic acidemia. Methionine- and valine-free; low in isoleucine and threonine. Use under medical
More informationHealth Canada Proposal to Improve Food Colour Labelling Requirements February 2010
Health Canada Proposal to Improve Food Colour Labelling Requirements February 2010 Bureau of Chemical Safety Food Directorate Health Products and Food Branch February 2010 Bureau of Chemical Safety, Food
More informationPure Encapsulations. Updates to the Supplement Facts Panel: What, Why and When. Andrew Halpner, PhD Vice President, Science & Technical Services
Pure Encapsulations Updates to the Supplement Facts Panel: What, Why and When Andrew Halpner, PhD Vice President, Science & Technical Services Webinar Disclosure Seminars, teleconferences and webinars
More informationComplying with Mexico s Food Labeling Regulations
Complying with Mexico s Food Labeling Regulations Presented by ESHA Research Wednesday, June 27, 2018 11:00 AM PDT 1:00 PM CDT 2:00 PM EDT ESHA Research ESHA Research was established in 1981 as the first
More informationCategory Specific Guidance for Temporary Marketing Authorization: Supplemented Food. February 2016
Category Specific Guidance for Temporary Marketing Authorization: Supplemented Food February 2016 Table of Contents Executive summary... 4 1.0 Introduction... 5 2.0 Background... 6 3.0 Supplemented food
More information2. Definitions. In these regulations, unless the context otherwise requires: - 1. (a) Act means the Food Safety and Standards Act, 2006 (34 of 2006);
Notice for operationalisation of Food Safety and Standards (Fortification of Foods) Regulations, 2017. CHAPTER 1: GENERAL 1. Short Title and commencement. - (1) these regulations may be called the Food
More informationβ-carotene (trans or cis isomer)
β-carotene (trans or cis isomer) Overview Natural beta-carotene contains a mixture of different isomers (cis and trans) of the betacarotene molecule. Synthetically produced beta-carotene is nature identical.
More informationUnderstanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationHealth Food Raw Materials Directory (First Batch)
Attachment Health Food Raw Materials Directory (First Batch) Nutrition Supplement Raw Materials Directory (draft) NO. Name of Raw Material Scope of the Crowd Daily Intake Amount Daily Minimum Amount Daily
More informationProduct Information: Phenex -1
Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake
More informationEVIDENCE FOR SAFETY AND EFFICACY OF FINISHED NATURAL HEALTH PRODUCTS NATURAL HEALTH PRODUCTS DIRECTORATE
EVIDENCE FOR SAFETY AND EFFICACY OF FINISHED NATURAL HEALTH PRODUCTS NATURAL HEALTH PRODUCTS DIRECTORATE December 2006 Version 2.0 Our mission is to help the people of Canada maintain and improve their
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 15 July /05 Interinstitutional File: 2003/0262 (COD)
COUNCIL OF THE EUROPEAN UNION Brussels, 15 July 2005 11268/05 Interinstitutional File: 2003/0262 (COD) DENLEG 36 SAN 123 CODEC 631 INFORMATION NOTE from : General Secretariat to : Delegations No. prev.
More informationPure Encapsulations. Updates to the Supplement Facts Panel: What, Why and When. Andrew Halpner, PhD Vice President, Science & Technical Services
Pure Encapsulations Updates to the Supplement Facts Panel: What, Why and When Andrew Halpner, PhD Vice President, Science & Technical Services Webinar Disclosure Seminars, teleconferences and webinars
More informationRyan Smith, Community Planning Department Manager. Zoning Bylaw Text Amendment for Cannabis Production and Retail Cannabis Sales
Report to Council Date: August 27, 2018 File: 1250-04 To: From: Subject: Report prepared by: City Manager Ryan Smith, Community Planning Department Manager Zoning Bylaw Text Amendment for Cannabis Production
More informationProduct Information: Similac For Spit-Up
Product Information: 1 of 5 A nutritionally complete milk-based formula with added rice starch to help reduce frequent spit up. Milk-based, reduced-lactose formula * suitable for lactose sensitivity. Our
More informationToday is the Day - Final Regulations on Nutrition and Supplement Facts Labels and Serving Sizes Officially Published in the Federal Register
Today is the Day - Final Regulations on Nutrition and Supplement Facts Labels and Serving Sizes Officially Published in the Federal Register By: Carolina M. Wirth and Alyson L. Wooten PharmD Today, Friday,
More informationProposed Excise Duty Framework for Cannabis Products
Department of Finance Canada Proposed Excise Duty Framework for Cannabis Products 1. Introduction and Purpose The Government of Canada is committed to providing regulated and restricted access to cannabis,
More informationProduct Information: Ensure Plus Therapeutic Nutrition
Product Information: Ensure Plus Therapeutic Nutrition 1 of 5 ENSURE PLUS provides concentrated calories and protein to help patients gain or maintain healthy weight. ENSURE PLUS can benefit patients who
More informationRe: Comments on OEHHA s request for information on coumarin
Ms. Michelle Ramirez Office of Environmental Health Hazard Assessment Proposition 65 Implementation P.O. Box 4010, MS-12B Sacramento, California 95812-4010 Via email: P65Public.Comments@oehha.ca.gov; Michelle.Ramirez@oehha.ca.gov
More informationFDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update
FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center
More informationProduct Information: Glucerna Therapeutic Nutrition Shake
Product Information: Glucerna Therapeutic Nutrition Shake 1 of 5 GLUCERNA THERAPEUTIC NUTRITION SHAKE has CARBSTEADY, including low glycemic carbohydrates clinically shown to help minimize blood glucose
More informationArchived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
More informationNDI: LOOKING BACK & AHEAD
NDI: LOOKING BACK & AHEAD Chi Hee Kim D i r e c t o r, W o r l d w i d e R e g u l a t o r y, G o v e r n m e n t a n d I n d u s t r y A f f a i r s H e r b a l i f e I n t e r n a t i o n a l o f A m
More informationRyan Smith, Community Planning Department Manager
Report to Council Date: April 9, 2018 File: 1200-40 To: From: Subject: City Manager Ryan Smith, Community Planning Department Manager Cannabis Regulatory Options Report prepared by: Kimberly Brunet, Planner
More informationProduct Information: Ensure Plus Therapeutic Nutrition
Product Information: Ensure Plus Therapeutic Nutrition 1 of 5 ENSURE PLUS provides concentrated calories and protein to help patients gain or maintain healthy weight. ENSURE PLUS can benefit patients who
More informationNutritional Information
Nutritional Information Honest Milk Step 1 Infant Formula Milk-based Infant Formula Milk powder for Infants 0-12 Months Indication Honest Milk Step 1 Infant Formula Milk Powder Includes Natural Defense
More informationUpdate from the European Commission s Working Group meeting on health claims, 31 March 2015
Update from the European Commission s Working Group meeting on health claims, 31 March 2015 There was discussion on a generic descriptor application and a number of health claims, including those mentioned
More informationRe: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.
VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;
More informationCannabis Legalization Proposed Bylaws
2018 April 03 Page 1 of 7 EXECUTIVE SUMMARY On 2017 April 13, the Government of Canada introduced Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal
More informationGUIDELINES FOR USE OF NUTRITION CLAIMS CAC/GL These guidelines relate to the use of nutrition claims in food labelling.
CAC/GL 23-1997 Page 1 of 6 GUIDELINES FOR USE OF NUTRITION CLAIMS CAC/GL 23-1997 Nutrition claims should be consistent with national nutrition policy and support that policy. Only nutrition claims that
More informationFood Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY
Statutory Instrument 120 of 2016 Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) [Cap 15:05 Section 1 Title 2 Interpretation ARRANGEMENT OF SECTIONS PART I PRELIMINARY 3 Inspection
More informationProduct Information: PediaSure (Institutional)
Product Information: PediaSure (Institutional) 1 of 5 PediaSure is a source of complete, balanced nutrition especially designed for children 1 to 13 years of age. May be used as the sole source of nutrition
More informationFood Labelling in Canada
Food Labelling in Canada Food Safety and Quality Summit, New Delhi Nitin Verma, Counsellor Agriculture & Regulatory Specialist Canadian Food Inspection Agency (CFIA) December 5, 2017 2017 Her Majesty the
More informationDietary Reference Intakes: Vitamins
Biotin Coenzyme in synthesis of fat, glycogen, and amino acids Liver and smaller b amounts in fruits and 6* meats 8* 12* 20* 2 of biotin in humans or animals were found. This does not mean biotin are limited,
More information2014 FDA/JIFSAN Food & Nutrition Webinar
2014 FDA/JIFSAN Food & Nutrition Webinar Medical Foods Shawne Suggs-Anderson, MMSc, _ RD Infant Formula and Medical Foods Staff ONLDS/CFSAN/FDA September 23, 2014 53 Main Objectives History What is a Medical
More informationCIAA Comments to DG SANCO Discussion Paper on the setting of maximum and minimum amounts for vitamins and minerals in foodstuffs
CIAA Comments to DG SANCO Discussion Paper on the setting of maximum and minimum amounts for vitamins and minerals in foodstuffs SETTING OF MAXIMUM AMOUNTS CIAA welcomes the DG SANCO initiative to consult
More informationTitle 17-A: MAINE CRIMINAL CODE
Maine Revised Statutes Title 17-A: MAINE CRIMINAL CODE Chapter 45: DRUGS 1101. DEFINITIONS As used in this Title, the following words shall, unless the context clearly requires otherwise, have the following
More informationProduct Information: EleCare Jr
Product Information: EleCare Jr 1 of 5 A 30 Cal/fl oz, nutritionally complete amino acid-based medical food for children age 1 and older who cannot tolerate intact or hydrolyzed protein. EleCare Jr is
More information10 th Seminar on. Nutrition Labeling, Claims and Communication Strategies. Nutrition Labelling and Claims in India An Update
10 th Seminar on Nutrition Labeling, Claims and Communication Strategies August 28 29, 2018 Renaissance Hotel, Kuala Lumpur, Malaysia Nutrition Labelling and Claims in India An Update Organizers Co-organizer
More informationNational Standards of People s Republic of China
National Standards of People s Republic of China GB 10767 2010 National food safety standard Older infants and young children formula Issued on: 2010-03-26 Implemented on: 2011-04-01 Issued by Ministry
More informationHealth Canada s Proposed Approach to Managing Caffeinated Energy Drinks
Health Canada s Proposed Approach to Managing Caffeinated Energy Drinks October 2011 Food Directorate, Health Products and Food Branch 1 Table of Contents Background... 3 Assessment of the Potential Health
More informationTHE NEW CANADIAN NATURAL HEALTH PERODUCT REGULATIONS
THE NEW CANADIAN NATURAL HEALTH PERODUCT REGULATIONS IMPACT AND OPPORTUNITY FOR CHINESE MEDICINE JULY 2006 Yili Bai, PhD Tel: 604-249-2896 Email: ybai@wellgenex.com Michael ZC Li, MSc, MD, MBA Tel: 604-249-2896
More information